{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pneumonia&page=2", "query": { "intervention": "Pneumonia", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pneumonia&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-21T11:37:58.717Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00621504", "title": "Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bacterial Pneumonia" ], "interventions": [ { "name": "Ceftaroline fosamil for Injection", "type": "DRUG" }, { "name": "IV Ceftriaxone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Clarithromycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 606, "start_date": "2008-01", "completion_date": "2009-06", "has_results": true, "last_update_posted_date": "2017-03-14", "last_synced_at": "2026-09-21T11:37:58.717Z", "location_count": 12, "location_summary": "Los Angeles, California • Pasadena, California • Sacramento, California + 9 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00621504" }, { "nct_id": "NCT01068548", "title": "Reducing Length of Stay for Veterans Hospitalized With Pneumonia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pneumonia" ], "interventions": [ { "name": "reminder", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 129, "start_date": "2011-02", "completion_date": "2011-11", "has_results": true, "last_update_posted_date": "2019-01-09", "last_synced_at": "2026-09-21T11:37:58.717Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01068548" }, { "nct_id": "NCT00000802", "title": "A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumonia, Pneumocystis Carinii", "HIV Infections" ], "interventions": [ { "name": "Atovaquone", "type": "DRUG" }, { "name": "Dapsone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 700, "start_date": null, "completion_date": "1997-07", "has_results": false, "last_update_posted_date": "2021-11-04", "last_synced_at": "2026-09-21T11:37:58.717Z", "location_count": 43, "location_summary": "Birmingham, Alabama • Los Angeles, California • Palo Alto, California + 30 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000802" }, { "nct_id": "NCT00410527", "title": "Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bacterial Infections" ], "interventions": [ { "name": "Merrem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institutes of Health Clinical Center (CC)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2006-08-11", "completion_date": "2007-05-22", "has_results": false, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-09-21T11:37:58.717Z", "location_count": 12, "location_summary": "Birmingham, Alabama • Newark, Delaware • Miami, Florida + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Newark", "state": "Delaware" }, { "city": "Miami", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00410527" }, { "nct_id": "NCT00028327", "title": "Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Lamivudine/Zidovudine", "type": "DRUG" }, { "name": "Nelfinavir mesylate", "type": "DRUG" }, { "name": "Efavirenz", "type": "DRUG" }, { "name": "Lamivudine", "type": "DRUG" }, { "name": "Zidovudine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2011-03-02", "last_synced_at": "2026-09-21T11:37:58.717Z", "location_count": 9, "location_summary": "Los Angeles, California • San Diego, California • San Francisco, California + 6 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00028327" }, { "nct_id": "NCT02130986", "title": "Procalcitonin Antibiotic Consensus Trial (ProACT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Lower Respiratory Tract Infection (LRTI)" ], "interventions": [ { "name": "Procalcitonin level", "type": "OTHER" }, { "name": "Results of procalcitonin (PCT) level to treating clinician", "type": "OTHER" }, { "name": "Provide procalcitonin guideline to treating clinician", "type": "OTHER" }, { "name": "Telephone Visit", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1664, "start_date": "2014-11-03", "completion_date": "2017-07-21", "has_results": true, "last_update_posted_date": "2019-01-15", "last_synced_at": "2026-09-21T11:37:58.717Z", "location_count": 13, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Orange, California + 8 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Orange", "state": "California" }, { "city": "Norwalk", "state": "Connecticut" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02130986" }, { "nct_id": "NCT04362813", "title": "Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia" ], "interventions": [ { "name": "Canakinumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 454, "start_date": "2020-04-30", "completion_date": "2020-12-22", "has_results": true, "last_update_posted_date": "2022-01-24", "last_synced_at": "2026-09-21T11:37:58.717Z", "location_count": 15, "location_summary": "Birmingham, Alabama • Glendale, California • San Francisco, California + 10 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04362813" }, { "nct_id": "NCT06181669", "title": "MASTERMIND-Pneumonia Study (Also Known as Pneumonia Direct Pilot)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pneumonia, Bacterial", "Ventilator Associated Pneumonia" ], "interventions": [ { "name": "Pathogen and Host Directed testing", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 173, "start_date": "2024-04-12", "completion_date": "2025-07-03", "has_results": false, "last_update_posted_date": "2026-04-27", "last_synced_at": "2026-09-21T11:37:58.717Z", "location_count": 4, "location_summary": "Detroit, Michigan • Royal Oak, Michigan • St Louis, Missouri + 1 more", "locations": [ { "city": "Detroit", "state": "Michigan" }, { "city": "Royal Oak", "state": "Michigan" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06181669" }, { "nct_id": "NCT03032380", "title": "Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Healthcare-associated Pneumonia (HCAP)", "Hospital Acquired Pneumonia (HAP)", "Ventilator Associated Pneumonia (VAP)" ], "interventions": [ { "name": "Cefiderocol", "type": "DRUG" }, { "name": "Meropenem", "type": "DRUG" }, { "name": "Linezolid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shionogi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2017-10-24", "completion_date": "2019-04-01", "has_results": true, "last_update_posted_date": "2020-11-13", "last_synced_at": "2026-09-21T11:37:58.717Z", "location_count": 15, "location_summary": "New Haven, Connecticut • DeLand, Florida • Chicago, Illinois + 12 more", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "DeLand", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Council Bluffs", "state": "Iowa" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT03032380" }, { "nct_id": "NCT07673250", "title": "Personalized Ventilator Settings for Patients on ECMO", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acute Respiratory Distress Syndrome (ARDS)", "Extracorporeal Membrane Oxygenation", "Respiratory Failure Patients Treated With ECMO", "Respiratory Failure, ICU", "Ventilator Induced Lung Injury" ], "interventions": [ { "name": "Personalized Positive End-Expiratory Pressure (PEEP)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 62, "start_date": "2026-09-01", "completion_date": "2031-06-30", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-09-21T11:37:58.717Z", "location_count": 1, "location_summary": "La Jolla, California", "locations": [ { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07673250" } ] }